Skip to main
GRAL

GRAIL Inc (GRAL) Stock Forecast & Price Target

GRAIL Inc (GRAL) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 33%
Buy 17%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

GRAIL Inc has seen a significant appreciation in its stock value, with shares rising nearly 90% in the past month, indicating strong investor confidence. The company's multi-cancer early detection technologies position it strategically within a lucrative market, projected to reach approximately $3.7 billion in the UK by 2026 and grow further to $4.0 billion by 2035. Furthermore, partnerships to capitalize on this total addressable market (TAM) and the recent positive data readout from the PATHFINDER 2 study bolster the outlook for GRAIL, even amid uncertainties regarding regulatory approvals and Medicare reimbursement.

Bears say

GRAIL Inc has consistently reported substantial net losses since its inception and is likely to continue incurring such losses due to ongoing studies and regulatory processes necessary for its multi-cancer early detection blood test. The company faces multiple significant risks, including potential delays in receiving Medicare reimbursement for its tests, adoption challenges for its innovative product, and competition from larger, established players in the diagnostics market, which could hinder its commercialization efforts. Additionally, challenges related to high selling, general, and administrative expenses and possible delays in clinical studies further exacerbate the company’s financial outlook, raising concerns about its ability to secure necessary financing for future growth.

GRAIL Inc (GRAL) has been analyzed by 6 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 17% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GRAIL Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GRAIL Inc (GRAL) Forecast

Analysts have given GRAIL Inc (GRAL) a Buy based on their latest research and market trends.

According to 6 analysts, GRAIL Inc (GRAL) has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $68.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $68.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GRAIL Inc (GRAL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.